Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Agilon Health, Inc. (NYSE:AGL – Free Report) by 1,028.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 789,703 shares of the company’s stock after buying an additional 719,751 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Agilon Health were worth $1,816,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in AGL. Goldman Sachs Group Inc. lifted its stake in Agilon Health by 6.6% in the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after acquiring an additional 311,158 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Agilon Health by 8.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company’s stock valued at $21,388,000 after acquiring an additional 398,027 shares in the last quarter. Nuveen LLC bought a new position in shares of Agilon Health in the 1st quarter valued at approximately $17,242,000. Amundi lifted its holdings in Agilon Health by 49.2% in the 1st quarter. Amundi now owns 1,484,709 shares of the company’s stock worth $5,939,000 after purchasing an additional 489,414 shares during the last quarter. Finally, Invesco Ltd. boosted its position in Agilon Health by 186.7% during the first quarter. Invesco Ltd. now owns 1,151,795 shares of the company’s stock worth $4,987,000 after purchasing an additional 750,046 shares during the period.
Agilon Health Stock Performance
NYSE AGL opened at $0.58 on Monday. The stock has a market cap of $238.38 million, a price-to-earnings ratio of -0.77 and a beta of 0.05. Agilon Health, Inc. has a 52-week low of $0.56 and a 52-week high of $6.08. The business has a 50 day simple moving average of $0.96 and a 200 day simple moving average of $1.68.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on AGL shares. Wells Fargo & Company cut their price target on Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Jefferies Financial Group cut their price objective on shares of Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a research report on Friday, August 15th. Zacks Research raised Agilon Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 21st. Sanford C. Bernstein reiterated a “market perform” rating and set a $1.40 target price (down from $4.00) on shares of Agilon Health in a research report on Wednesday, August 20th. Finally, Robert W. Baird lowered their target price on shares of Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Four research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Agilon Health has an average rating of “Hold” and an average price target of $2.73.
Read Our Latest Analysis on Agilon Health
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
- Five stocks we like better than Agilon Health
- How to Choose Top Rated Stocks
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGL – Free Report).
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
